Reduced platelet aggregation by effects of pentoxifylline on vascular prostacyclin isomerase and platelet cyclic AMP
- 31 December 1983
- journal article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 14 (1) , 161-162
- https://doi.org/10.1016/0306-3623(83)90091-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Biological significance and therapeutic potential of prostacyclinJournal of Medicinal Chemistry, 1980
- Vasodilation and inhibition of platelet aggregation by prostacyclins with modified ω-side chainProstaglandins and Medicine, 1979
- DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLINThe Lancet, 1978
- The effect of pentoxifylline on the 3′,5′-cyclic AMP-system in bovine plateletsInternational Journal of Biochemistry, 1977
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsNature, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- The Pathogenesis of AtherosclerosisNew England Journal of Medicine, 1976
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962